Virginia Commonwealth University, U.S.
New developments from Virginia Commonwealth University, U.S., outlined recently
Published in Medical Patent Week, January 7th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Virginia Commonwealth University, U.S.
Report 1: Virginia Commonwealth University researchers have developed a unique anti-sickling agent that may one day be effective in treating sickle cell disease, a painful and debilitating genetic blood disorder that affects approximately 80,000 Americans.
The research team led by Donald Abraham, PhD, the Alfred and Frances Burger Professor of Biological and Medicinal Chemistry, in the Department of Medicinal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
Source: Medical Patent Week (2007-01-07)
More Articles from Medical Patent Week
- Aneurysm
Research from University of Montreal, Biomaterials Research Center reveals new findings on aneurysm - Avian Influenza
HepaLife's PBS-1 cells for avian influenza vaccine achieve research objective - Business Update
Atlanta-based pharmaceutical company focuses on central nervous system - Business Update
Cephalon provides update related to final Nuvigil labeling - Business Update
ClearLab's AquaSoft Singles honored in BRANDPACKAGING's 2007 Design Gallery - Business Update
CutisPharma completes progesterone vaginal suppository product line - More from this issue of Medical Patent Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
